Rchr
J-GLOBAL ID：201201080129952358
Update date: Aug. 29, 2020
Tsuda Masahiro
ツダ マサヒロ | Tsuda Masahiro
MISC (5)：
M Iwai, R Chen, Z Li, T Shiuchi, J Suzuki, A Ide, M Tsuda, M Okumura, LJ Min, M Mogi, et al. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. CIRCULATION. 2005. 112. 11. 1636-1643
JM Li, M Iwai, TX Cui, J Min, M Tsuda, J Iwanami, J Suzuki, M Mogi, M Horiuchi. Effect of azelnidipine on angiotensin II-mediated growth-promoting signaling in vascular smooth muscle cells. MOLECULAR PHARMACOLOGY. 2005. 67. 5. 1666-1673
動脈硬化抑制に関わるAT1受容体拮抗薬とエストロゲンの作用機序:酸化ストレスに対する相互作用を中心に. 埼玉医科大学雑誌. 2005. 32. 1-11
M Tsuda, M Iwai, JM Li, HS Li, LJ Min, A Ide, M Okumura, J Suzuki, M Mogi, H Suzuki, et al. Inhibitory effects of AT(1) receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress. HYPERTENSION. 2005. 45. 4. 545-551
Zhen Li, Masaru Iwai, Lan Wu, Hong-Wei Liu, Rui Chen, Toyohisa Jinno, Jun Suzuki, Masahiro Tsuda, Xin-Yu Gao, Midori Okumura, et al. Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis. Hypertension. 2004. 44. 5. 758-763
Work history (3)：
2008 - - 埼玉医科大学 医学部腎臓内科 助教
1972 - 2006 Saitama Medical University Internal Medicine (Nephrology), Faculty of Medicine
Saitama Medical University Faculty of Medicine Assistant Professor
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
